Celgene

REBLOZYL - Cost

Last Updated: April 1st, 2024

HCPCS:

J0896

HCPCS Code Descriptor:

Injection, luspatercept-aamt, 0.25 mg

Medicare Payment Limit:

The REBLOZYL Medicare Payment Limit is $39.983

Average Sale Price:

REBLOZYL ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The REBLOZYL Medicare Co-insurance percentage is 20%. REBLOZYL's Medicare Co-insurance amount is $8 per HCPCS unit.

APC Code:

The Reblozyl APC Code is: 9347

APC Payment Limit:

The APC Payment Limit for REBLOZYL is available. Login to view.

Reblozyl Cost Information:

REBLOZYL, a product of Celgene, became effective on July, 1, 2020 and is aligned to HCPCS J0896. REBLOZYL has two NDCs mapped to J Code: J0896 with no issues in these alignments. Historical prices show an upward trend of increases of a round one percent every six months.

ACCESS PRICING AND MORE BY REGISTERING

Reblozyl’s wholesale acquisition cost (WAC) information was last updated on:
January 1, 2024
Reblozyl’s average wholesale price (AWP) information was last updated on:
January 1, 2024